2007
DOI: 10.1164/rccm.200609-1279oc
|View full text |Cite
|
Sign up to set email alerts
|

Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary Fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

8
159
1
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 158 publications
(172 citation statements)
references
References 61 publications
8
159
1
2
Order By: Relevance
“…Effects of age and gender on serum CCL2 and CXCL8 concentrations were not significant. In humans, both CXCL8 and CCL2 concentrations were found to be increased in blood (Ziegenhagen et al, 1998a;Suga et al, 1999;Fujiwara et al, 2012) and bronchoalveolar lavage fluid (BALF) (Capelli et al, 2005;Antoniou et al, 2006;Baran et al, 2007) of IPF patients compared with healthy volunteers and correlated with lung function (Capelli et al, 2005;Emad and Emad, 2007;Martina et al, 2009;Vasakova et al, 2009), disease progression (Ziegenhagen et al, 1998b;Totani et al, 2002), and outcome (Shinoda et al, 2009;Richards et al, 2012). Furthermore, several studies suggested an involvement of the chemokine CCL2 in the pathogenesis of IPF, notably through its action on resident pulmonary fibroblast and circulating fibrocytes, promoting the generation of abundant extracellular matrix in the lungs (Gharaee-Kermani et al, 1996;Phillips et al, 2004;Moore et al, 2005;Inomata et al, 2014).…”
Section: Cxcl8 and Ccl2 Concentrationsmentioning
confidence: 99%
“…Effects of age and gender on serum CCL2 and CXCL8 concentrations were not significant. In humans, both CXCL8 and CCL2 concentrations were found to be increased in blood (Ziegenhagen et al, 1998a;Suga et al, 1999;Fujiwara et al, 2012) and bronchoalveolar lavage fluid (BALF) (Capelli et al, 2005;Antoniou et al, 2006;Baran et al, 2007) of IPF patients compared with healthy volunteers and correlated with lung function (Capelli et al, 2005;Emad and Emad, 2007;Martina et al, 2009;Vasakova et al, 2009), disease progression (Ziegenhagen et al, 1998b;Totani et al, 2002), and outcome (Shinoda et al, 2009;Richards et al, 2012). Furthermore, several studies suggested an involvement of the chemokine CCL2 in the pathogenesis of IPF, notably through its action on resident pulmonary fibroblast and circulating fibrocytes, promoting the generation of abundant extracellular matrix in the lungs (Gharaee-Kermani et al, 1996;Phillips et al, 2004;Moore et al, 2005;Inomata et al, 2014).…”
Section: Cxcl8 and Ccl2 Concentrationsmentioning
confidence: 99%
“…Male mice, aged 6-12 weeks, underwent intraperitoneal injections as previously described (14). Briefly, mice were injected with 0.035 U bleomycin/g or PBS (vehicle control) on Days 1,4,8,11,15,18,22,and 25.…”
Section: Bleomycin Studiesmentioning
confidence: 99%
“…Furthermore, the E26 transformation-specific sequence (ets) family of transcription factors is linked to extracellular matrix remodeling (12,13), a process that is conserved in IPF. Our laboratory demonstrated that the hematopoietic growth factor macrophage colony-stimulating factor (M-CSF) is important in the development of pulmonary fibrosis (14), and M-CSF induces the activation of transcription factor ets-2 via phosphorylation at threonine-72 (15,16). A transgenic mouse containing hypomorphic ets-2 alleles, where the critical threonine-72 residue is mutated to alanine (ets-2 A72/A72), exhibits decreased expression of matrix metalloproteinase (MMP)-3 and MMP-9 in cells stimulated with M-CSF (17).…”
mentioning
confidence: 99%
“…The disadvantage of this model is that the fibrosis is patchy (depending on lung deposition of the instillate) and self-resolving beyond a certain period. While the development of fibrosis in response to bleomycin is T-cell independent (Helene et al, 1999;Szapiel et al, 1979), the development of fibrotic lesions is dependent on the release of chemokines (CCL2 or CCL12) and the recruitment of inflammatory cells including neutrophils, monocytes, and lymphocytes (Baran et al, 2007;Inoshima et al, 2004;Moore et al, 2001;Moore et al, 2006;Smith et al, 1995;Zhang et al, 1994). Pro-fibrotic cytokines (e.g.…”
Section: Bleomycinmentioning
confidence: 99%